Sponsors, CROs and websites have a responsibility to comply with the study protocol, laws and regulations of the authorities. In general, the purpose of a clinical study is to collect safety and efficacy data for a particular medical device. In the case of industry-sponsored studies (for example. B regulatory studies of new drugs or testing devices, post-market, observational or registration studies), the proponent or its clinical research organization will submit a first CTA project. Like your auto or medical insurance, websites, CROs and sponsors typically provide clinical study insurance to protect themselves or the parties involved in a clinical trial. A clinical trial contract initiated by the investigator is required when an industrial sponsor provides the device or drug to be examined and/or the necessary funding for the study. This section of the agreement is often overlooked by sponsors, CROs and websites. The purpose of this section is to explicitly state the description of the research project. You want to document the overall purpose of the agreement in this section. Finally, this section of the agreement should clearly specify where the website should send invoices (name and contact information of the person) as well as payment terms (example: payment is made within 45 days). This agreement is either a subcontracting or a subcontracting, in which a reference site recruits one or more sub-sites on which the clinical trial is carried out. A definition of the Clinical Trials Agreement defines the conditions and obligations that apply to all parties when a clinical trial is conducted.

The agreement must be executed completely before the study is activated. Both the proponent and the trial site have key objectives related to the conduct of a clinical study. In the United States, the Sunshine Act strengthens control over payments to health organizations and health care professionals. The project description contains the necessary information on the nature of the agreement. Whether you are new to clinical research contracts or a ninja contract, at any time, there is at least one agreement that you can imagine that one could have formulated otherwise. In the case of an industry-sponsored clinical trial, such an agreement may be reached with the sponsor or a clinical research organization that manages the study for the sponsor. A CTA defines the scope of the work and formalizes the agreements between the parties for the completion of the study. It contains legal and financial conditions related to the completion of the study by the university. The contract does not need to be written in legal form. In order to ensure that all parties have a clear understanding of the definitions of legal concepts, the treaty should be written in clear language. The tasks, results and responsibilities of the test site must be clearly written and detailed to avoid confusion as to what is necessary to carry out the study. This type of agreement can be initiated by a sponsor or reviewer.

A clinical trial agreement, initiated by a sponsor, is required if the drug or device under review has financial support. A sponsored project includes negotiating, auditing and implementing legal agreements from external funding sources. Coordination between all parties, including the auditor and the external source of funding, is essential to ensure the success of the contract with mutually acceptable terms. But what if the clinical site provides the sponsor with incomplete or false data? Or is he hesitant to allow a CRO to monitor data in the field? For industry-sponsored clinical trials, the clinical contract manager will audit a CTA within two weeks and, after receiving responses to requests from the investigator/staff, will refer the revised project to the sponsor.